Answers are grounded in this paper and cite their sources.
Establishing similarity is of critical importance during the development of generic treatments. SPIL and reference DXR HCl liposome injections were shown to be comparable with regards to antitumour activity, toxicity and pharmacokinetics.
No takes yet. Share an insight, caveat, or question.
Burade et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: